These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 18432916)

  • 1. Production of anti-peptide antisera.
    Carter JM
    Curr Protoc Immunol; 2003 Aug; Chapter 9():Unit 9.3. PubMed ID: 18432916
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthetic peptides for production of antibodies that recognize intact proteins.
    Grant GA
    Curr Protoc Immunol; 2003 Aug; Chapter 9():Unit 9.2. PubMed ID: 18432915
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Production of antisera to synthetic peptides.
    Gullick WJ
    Methods Mol Biol; 1994; 32():389-99. PubMed ID: 7951738
    [No Abstract]   [Full Text] [Related]  

  • 4. Recombinant peptides as immunogens: a comparison of protocols for antisera production using the pGEX system.
    Oettinger HF; Pasqualini R; Bernfield M
    Biotechniques; 1992 Apr; 12(4):544-9. PubMed ID: 1503757
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Polyclonal Peptide Antisera.
    Pihl TH; Illigen KE; Houen G
    Methods Mol Biol; 2015; 1348():103-7. PubMed ID: 26424267
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Production of antisera using peptide conjugates.
    Adrian TE
    Methods Mol Biol; 1997; 73():239-49. PubMed ID: 9031212
    [No Abstract]   [Full Text] [Related]  

  • 7. Neutralization of HPV16, 18, 31, and 58 pseudovirions with antisera induced by immunizing rabbits with synthetic peptides representing segments of the HPV16 minor capsid protein L2 surface region.
    Kondo K; Ishii Y; Ochi H; Matsumoto T; Yoshikawa H; Kanda T
    Virology; 2007 Feb; 358(2):266-72. PubMed ID: 17010405
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthetic peptide vaccine design: synthesis and properties of a high-density multiple antigenic peptide system.
    Tam JP
    Proc Natl Acad Sci U S A; 1988 Aug; 85(15):5409-13. PubMed ID: 3399498
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Qualitative and quantitative differences in the immune response to foot-and-mouth disease virus antigens and synthetic peptides.
    Francis MJ; Fry CM; Rowlands DJ; Brown F
    J Gen Virol; 1988 Oct; 69 ( Pt 10)():2483-91. PubMed ID: 2844964
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A novel and easy method for the production of recombinant peptides for use in the generation of monospecific antisera against Lama glama IgG2b and IgG2c subclasses.
    Saccodossi N; De Simone E; Leoni J
    J Immunol Methods; 2006 Jun; 313(1-2):214-8. PubMed ID: 16820167
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Production of peptide antisera specific for mouse and rat proinsulin C-peptide 2.
    Blume N; Madsen OD; Kofod H; Dyrberg T
    Biomed Biochim Acta; 1990; 49(12):1247-51. PubMed ID: 1711321
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunization with synthetic peptides containing epitopes of the class 1 outer-membrane protein of Neisseria meningitidis: production of bactericidal antibodies on immunization with a cyclic peptide.
    Christodoulides M; McGuinness BT; Heckels JE
    J Gen Microbiol; 1993 Aug; 139(8):1729-38. PubMed ID: 7691983
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Production and characterization of antibodies against synthetic peptides.
    Hancock DC; Evan GI
    Methods Mol Biol; 1998; 80():15-22. PubMed ID: 9664360
    [No Abstract]   [Full Text] [Related]  

  • 14. Antibody responses to a synthetic peptide-based malaria vaccine candidate: influence of sequence variants of the peptide.
    Etlinger HM; Renia L; Matile H; Manneberg M; Mazier D; Trzeciak A; Gillessen D
    Eur J Immunol; 1991 Jun; 21(6):1505-11. PubMed ID: 2044658
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunization and affinity purification of antibodies using resin-immobilized lysine-branched synthetic peptides.
    Butz S; Rawer S; Rapp W; Birsner U
    Pept Res; 1994; 7(1):20-3. PubMed ID: 8019057
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Production and characterization of human antirenin antibodies prepared with synthetic immunogens].
    Galen FX; Evin G; Carelli C; Bouhnik J; Michel JB; Ferhentz JA; Le N'Guyen D; Seyer R; Carlson WD; Haber E
    Arch Mal Coeur Vaiss; 1988 Jun; 81 Spec No():199-201. PubMed ID: 2461182
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Production of antisera to human immunoglobins G and A by immunizing horses].
    Noyola MS; Baiester SM
    Probl Gematol Pereliv Krovi; 1982 May; 27(5):58-9. PubMed ID: 7100148
    [No Abstract]   [Full Text] [Related]  

  • 18. Enrichment and characterization of angiotensin II using affinity and high pressure liquid chromatography. Part I. Affinity purification and characterization of Ang II antiserum.
    Hermann K; Kimura B; Phillips MI
    Biochem Biophys Res Commun; 1986 Apr; 136(2):685-700. PubMed ID: 3085674
    [No Abstract]   [Full Text] [Related]  

  • 19. [Preparation of monospecific antisera to IgA in laboratory animals using cascade immunization without preliminary isolation of the antigen].
    Liubinskaia MM; Chernokhvostova EV
    Biull Eksp Biol Med; 1987 Sep; 104(9):343-4. PubMed ID: 3663922
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Developments in ELISA: the use of biotinylated peptides in the assessment of antipeptide sera.
    Tribbick G
    Am Biotechnol Lab; 1993 Dec; 11(13):32. PubMed ID: 7764281
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.